Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
<Group xmlns="http://hl7.org/fhir">
<id value="33398"/>
<meta>
<versionId value="11"/>
<lastUpdated value="2024-11-16T20:03:47.547Z"/>
<profile
value="http://hl7.org/fhir/uv/ebm/StructureDefinition/metaanalysis-eligibility-criteria"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>[No data.]</p></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact">
<valueRelatedArtifact>
<type value="cite-as"/>
<citation
value="StudyEligibilityCriteria: Type 2 diabetes and elevated BMI in 2016 meta-analysis [Database Entry: FHIR Group Resource]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 33398. Revised 2022-05-26. Available at: https://fevir.net/resources/Group/33398. Computable resource at: https://fevir.net/resources/Group/33398."/>
</valueRelatedArtifact>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-author">
<valueContactDetail>
<name value="Brian S. Alper"/>
</valueContactDetail>
</extension>
<url value="https://fevir.net/resources/Group/33398"/>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="urn:ietf:rfc:3986"/>
<value value="https://fevir.net/FOI/33398"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<name value="Type_2_diabetes_and_elevated_BMI_in_2016_meta_analysis"/>
<title
value="StudyEligibilityCriteria: Type 2 diabetes and elevated BMI in 2016 meta-analysis"/>
<status value="active"/>
<date value="2022-05-26T13:50:22.651Z"/>
<publisher value="Computable Publishing LLC"/>
<contact>
<telecom>
<system value="email"/>
<value value="support@computablepublishing.com"/>
</telecom>
</contact>
<description
value="A conceptual group with 2 characteristics for study participant eligibility criteria that were used for a meta-analysis."/>
<useContext>
<code>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="evidence-communication"/>
<display value="Evidence Communication"/>
</code>
<valueCodeableConcept>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="StudyEligibilityCriteria"/>
<display value="StudyEligibilityCriteria"/>
</coding>
</valueCodeableConcept>
</useContext>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
<type value="person"/>
<membership value="conceptual"/>
<combinationMethod value="all-of"/>
<characteristic>
<code>
<coding>
<system value="http://snomed.info/sct"/>
<code value="64572001"/>
<display value="Disease (disorder)"/>
</coding>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="44054006"/>
<display value="Diabetes mellitus type 2 (disorder)"/>
</coding>
</valueCodeableConcept>
<exclude value="false"/>
<description value="Type 2 diabetes"/>
</characteristic>
<characteristic>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="39156-5"/>
<display value="Body mass index (BMI) [Ratio]"/>
</coding>
</code>
<valueQuantity>
<value value="25"/>
<comparator value=">"/>
<unit value="kg/m2"/>
<system value="http://unitsofmeasure.org"/>
<code value="kg/m2"/>
</valueQuantity>
<exclude value="false"/>
<description value="BMI > 25 kg/m2"/>
</characteristic>
</Group>